Imperative Care, Inc. announces positive results from the SYMPHONY-PE Trial evaluating Symphony® Thrombectomy System in the ...

Disney’s ABC said “Jimmy Kimmel Live!” “will be will be pre-empted indefinitely,” a spokesperson confirmed to NBC News, after ...

Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior ...

Phillips 66 is transforming its refining business through cost reductions and strategic portfolio shifts, aiming to become a ...

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that 48-week clinical data from the ...

Soleno Therapeutics faces scrutiny over Vykat safety after a patient death. Click here to find out why I rate SLNO a Hold.

The executive who leads Intel’s business with the U.S. government said Tuesday that he has “made the difficult decision” to ...

MSU will host a DARPAConnect Regional Pop-Up on Wednesday, Sept. 24, from 8:30 a.m. to 4 p.m. in the Strand Union Building.

Protagonist Therapeutics (PTGX) announced new data from the Phase 3 ICONIC-ADVANCE 1 and 2 studies which assessed the superiority of icotrokinra, ...

Relmada Therapeutics ( ($RLMD) ) has shared an announcement. On September 17, 2025, Relmada Therapeutics updated its corporate presentation, ...

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profileKT-621 ...